Diabetes Mellitus
Endocrinology Research Centre (Moscow); Russian Association of Endocrinology (Moscow) ISSN 2072-0351
Dergi hakkında
The “Diabetes Mellitus” is a peer-reviewed research and clinical journal published quarterly since 1998 under the auspices of Russian Association of Endocrinologists and Federal Endocrinology Research Centre (Moscow).
Its content focuses on original papers on clinical, experimental and academic studies, but also includes literature reviews, lectures, case studies and supplementary materials. General discourse of the journal is dedicated to the key aspects of diabetology, encompassing etiology, epidemiology and pathogenesis of diabetes mellitus, novel diagnostic and therapeutic methods, as well as prevention and management of acute and late complications of diabetes mellitus and associated conditions.
The intended primary audience of the journal is medical professionals (including diabetologists, endocrinologists, general practitioners, family physicians and pediatricians), scientists and academicians working in the area of endocrinology and diabetology.
In 2014 “Diabetes Mellitus” has become fully bilingual, now featuring full-text English versions of all published materials, and adopted the Gold Open Access distribution model.
The current editorial board understanding of the journal’s mission is as following:
- to facilitate the exchange of clinical experience and scientific data between Russian-speaking and international diabetology communities;
- to inform Russian-speaking medical professionals about the relevant and high-quality evidence-based clinical data.
- Editör
- LLC "UP Print"
- Yayın dilleri
- English, Russian
- Yer aldığı dizinler
- DOAJ –The Directory of Open Access Journals
- EBSCOhost
- Scholar Google
- Scopus
- Ulrich's Periodicals Directory
Makaleler 1.112
Filtrele ve sıralaEpidemiological aspects of type 2 diabetes in the young
Cilt 2012/15, Sayı 1-legacy-1313
Epidemiological characteristics of diabetes mellitus and its complications in the Omsk region
Cilt 2010/13, Sayı 2-legacy-1305
Epidemiology of diabetes mellitus and microvascular complications
Cilt 2011/14, Sayı 3-legacy-1311
Epidemiology of diabetes mellitus and prognosis of its prevalence in the Russian Federation
Cilt 2011/14, Sayı 1-legacy-1309
European Medicines Agency (EMA) announces termination of Avandia (rosiglitazone usage in Europe)
Cilt 2010/13, Sayı 3-legacy-1306
European Society Pediatric Endocrinologists Congress, 22-25 September 2010, Prague
Cilt 2010/13, Sayı 3-legacy-1306
Evaluation of effectiveness of different modes of per os therapy of painful diabetic peripheral polyneuropathy with alpha-lipoic acid
Cilt 2010/13, Sayı 2-legacy-1305
Excretion of amine nitrogen and ammonia in urine of pregnant women with type 1 diabetes mellitus
Cilt 2010/13, Sayı 4-legacy-1307
Experience of the use of liraglutide (Victoza) in women with type 2 diabetes mellitus and obesity
Cilt 2011/14, Sayı 2-legacy-1310
Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
Cilt 2010/13, Sayı 3-legacy-1306
Experience with the treatment of diabetic foot syndrome in Barnaul
Cilt 2011/14, Sayı 4-legacy-1312
Expert committee on introduction of incretin-based therapy in Russia: advance and failure
Cilt 2012/15, Sayı 3-legacy-1315
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
Cilt 2012/15, Sayı 2-legacy-1314
Factors of tubulointerstitial lesions in diabetic kidneys
Cilt 2009/12, Sayı 4-legacy-1302
Factors promoting development of renal tubulointerstitial lesions in patients with diabetes mellitus
Cilt 2010/13, Sayı 3-legacy-1306
Features of proliferative process in patients with diabetic retinopathy
Cilt 2012/15, Sayı 2-legacy-1314
First GLP-1 analog liraglutide: the result of clinical trails on efficacy
Cilt 2011/14, Sayı 4-legacy-1312
Friedreichs ataxia in a diabetic patient
Cilt 2010/13, Sayı 2-legacy-1305
Functional activity and peripheral insulin resistance in patients with different types of onset of diabetesmellitus
Cilt 2012/15, Sayı 3-legacy-1315
Genetics of monegenic forms of diabetes mellitus
Cilt 2011/14, Sayı 1-legacy-1309
Glibenclamide - profile of efficacy and safety
Cilt 2011/14, Sayı 3-legacy-1311
Glibenclamide therapy: pros and cons
Cilt 2011/14, Sayı 3-legacy-1311
Glycemic control on development of chronic heart failure in patients with type 2 diabetes mellitus
Cilt 2012/15, Sayı 2-legacy-1314
Harold Himsworth, founder of diabetes classification: 105th anniversary of his birthday
Cilt 2010/13, Sayı 1-legacy-1304
HLA-haplotypes, anti- cell antibodies: their role in prognostication of type 1 diabetes mellitus (results of 11-year observation)
Cilt 2010/13, Sayı 4-legacy-1307